RS50035B - Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje - Google Patents

Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje

Info

Publication number
RS50035B
RS50035B YUP-932/01A YUP93201A RS50035B RS 50035 B RS50035 B RS 50035B YU P93201 A YUP93201 A YU P93201A RS 50035 B RS50035 B RS 50035B
Authority
RS
Serbia
Prior art keywords
pharmaceutical composition
phenofibrate
procedure
production
composition containing
Prior art date
Application number
YUP-932/01A
Other languages
English (en)
Inventor
Bruno Criere
Pascal Suplie
Philippe Chenevier
Original Assignee
Laboratoires Des Produits Ethiques Ethypharm,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547923&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS50035(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoires Des Produits Ethiques Ethypharm, filed Critical Laboratoires Des Produits Ethiques Ethypharm,
Publication of YU93201A publication Critical patent/YU93201A/sh
Publication of RS50035B publication Critical patent/RS50035B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Farmaceutska kompozicija koja sadrži mikroniziran fenofibrat, površinski aktivno sredstvo i vezujući derivat celuloze kao adjuvans za rastvaranje,naznačena time, što sadrži količinu fenofibrata veću od ili jednaku sa 60% masenih. Prijava sadrži još 12 zahteva.
YUP-932/01A 1999-07-09 2000-07-07 Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje RS50035B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908923A FR2795961B1 (fr) 1999-07-09 1999-07-09 Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation

Publications (2)

Publication Number Publication Date
YU93201A YU93201A (sh) 2004-09-03
RS50035B true RS50035B (sr) 2008-11-28

Family

ID=9547923

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-932/01A RS50035B (sr) 1999-07-09 2000-07-07 Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje

Country Status (37)

Country Link
US (4) US7101574B1 (sr)
EP (3) EP1523983B1 (sr)
JP (2) JP4841092B2 (sr)
KR (3) KR20020025188A (sr)
CN (2) CN1204885C (sr)
AT (3) ATE399006T1 (sr)
AU (1) AU782282B2 (sr)
BG (1) BG65504B1 (sr)
BR (1) BR0012335A (sr)
CA (1) CA2377909C (sr)
CY (1) CY1106206T1 (sr)
CZ (1) CZ300094B6 (sr)
DE (3) DE60019120T2 (sr)
DK (3) DK1523983T3 (sr)
EA (1) EA004294B1 (sr)
EE (1) EE04995B1 (sr)
ES (3) ES2235919T3 (sr)
FR (1) FR2795961B1 (sr)
GE (1) GEP20043287B (sr)
HK (3) HK1044894B (sr)
HR (1) HRP20020111B1 (sr)
HU (1) HU229044B1 (sr)
IL (2) IL147499A0 (sr)
IS (1) IS2157B (sr)
ME (1) ME01361B (sr)
MX (1) MXPA02000324A (sr)
NO (1) NO333301B1 (sr)
NZ (1) NZ516416A (sr)
PL (1) PL212082B1 (sr)
PT (3) PT1194140E (sr)
RS (1) RS50035B (sr)
SI (2) SI1194140T1 (sr)
SK (1) SK287484B6 (sr)
TR (1) TR200200008T2 (sr)
UA (1) UA72925C2 (sr)
WO (1) WO2001003693A1 (sr)
ZA (1) ZA200200169B (sr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
FR2819720B1 (fr) * 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
EP1551372B8 (en) * 2002-09-20 2018-08-01 Alpharma Pharmaceuticals LLC Sequestering subunit and related compositions and methods
WO2004028506A1 (en) * 2002-09-24 2004-04-08 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
CN100367947C (zh) * 2002-12-04 2008-02-13 徐州恩华赛德药业有限责任公司 具有抗高血脂症的含非诺贝特的药物组合物
EP1832285A1 (en) * 2002-12-17 2007-09-12 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
DE60313359T2 (de) * 2002-12-17 2008-01-03 Abbott Gmbh & Co. Kg Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
EP1643975A2 (en) * 2003-07-02 2006-04-12 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8026281B2 (en) * 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate
CN101128189A (zh) * 2005-02-25 2008-02-20 弗·哈夫曼-拉罗切有限公司 药物物质分散性改善的片剂
CN101212962A (zh) * 2005-03-30 2008-07-02 特瓦制药工业有限公司 包含薄荷醇或peg/泊洛沙姆的非诺贝特的改进制剂
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
US20090210197A1 (en) * 2006-05-23 2009-08-20 Intelemetrix Ltd Data accessing system and method
EP2526932B1 (en) 2006-06-19 2017-06-07 Alpharma Pharmaceuticals LLC Pharmaceutical composition
KR100767349B1 (ko) * 2006-08-01 2007-10-17 삼천당제약주식회사 페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법
EP1923053A1 (en) * 2006-09-27 2008-05-21 Novartis AG Pharmaceutical compositions comprising nilotinib or its salt
WO2008063301A2 (en) * 2006-10-11 2008-05-29 Alpharma, Inc. Pharmaceutical compositions
JP4993274B2 (ja) * 2006-12-05 2012-08-08 日医工株式会社 フェノフィブラート含有製剤組成物の製造方法
AU2008338442A1 (en) * 2007-12-17 2009-06-25 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
FR2940118B1 (fr) * 2008-12-24 2013-08-09 Ethypharm Sa Formulation pharmaceutique de fenofibrate nanonise
WO2010092925A1 (ja) * 2009-02-12 2010-08-19 あすか製薬株式会社 固体分散体とその医薬組成物、並びにそれらの製造方法
CN101502497B (zh) * 2009-03-06 2010-11-10 安徽省药物研究所 非诺贝特药物组合物
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
KR101202994B1 (ko) * 2010-04-12 2012-11-21 한미사이언스 주식회사 페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US20140255480A1 (en) * 2011-09-07 2014-09-11 Ethypharm Pharmaceutical formulation of nanonized fenofibrate
KR101334585B1 (ko) * 2012-05-29 2013-12-05 주식회사 브이터치 프로젝터를 통해 표시되는 정보를 이용하여 가상터치를 수행하는 원격 조작 장치 및 방법
US8722083B2 (en) 2012-06-25 2014-05-13 Mylan, Inc. Fenofibrate formulation
WO2014091318A1 (en) 2012-12-11 2014-06-19 Lupin Atlantis Holdings, S.A. Reduced dose pharmaceutical compositions of fenofibrate
KR20160094987A (ko) * 2013-12-04 2016-08-10 다우 글로벌 테크놀로지스 엘엘씨 셀룰로오스 유도체와 액체 희석제의 혼합물의 제조 방법
CN104352466A (zh) * 2014-11-17 2015-02-18 辰欣药业股份有限公司 一种非诺贝特组合物及其制剂
CN107961224B (zh) * 2017-12-06 2021-05-04 齐鲁制药(海南)有限公司 一种阿昔替尼片及其制备方法
KR102407512B1 (ko) 2019-10-30 2022-06-13 주식회사 대웅테라퓨틱스 피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물
CN112121022A (zh) * 2020-09-25 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物及其制备方法
WO2022071768A1 (en) * 2020-09-29 2022-04-07 Addpharma Inc. A pharmaceutical composition comprising fenofibrate particles with improved bioavailability
CN112121023A (zh) * 2020-09-30 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH543472A (fr) 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
US4058552A (en) 1969-01-31 1977-11-15 Orchimed Sa Esters of p-carbonylphenoxy-isobutyric acids
GB1579818A (en) 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
DE2966564D1 (en) 1978-11-20 1984-02-23 American Home Prod Therapeutic compositions with enhanced bioavailability and process for their preparation
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
FR2494112B1 (sr) * 1980-11-19 1986-01-10 Laruelle Claude
GB8414221D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Unit dosage form
GB8414220D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
FR2602423B1 (fr) 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4752470A (en) 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
US4895725A (en) * 1987-08-24 1990-01-23 Clinical Technologies Associates, Inc. Microencapsulation of fish oil
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
DK0537139T3 (da) 1990-07-02 1994-08-22 Boehringer Mannheim Gmbh Fremgangsmåde til fremstilling af formede, pressede dosisenheder med forsinket frigørelse og dertil svarende dosisenhed
JP3125221B2 (ja) * 1990-09-01 2001-01-15 大正製薬株式会社 ソファルコン含有固形製剤
JP3037393B2 (ja) * 1990-10-22 2000-04-24 大正薬品工業株式会社 経口投与用固形薬剤の製造方法
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
DE69127275T2 (de) * 1991-06-21 1998-03-12 Ilsan Ilac Ve Hammaddeleri San Neues galenisches Verfahren für Omeprazol enthaltende Pellets
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr) 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
DE19608750A1 (de) 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
PL330864A1 (en) * 1996-06-28 1999-06-07 Schering Corp Orally administered composition containing antimycotic compounds of triazole
FR2758461A1 (fr) 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
AU2005299A (en) * 1997-12-20 1999-07-12 Genencor International, Inc. Fluidized bed matrix granule
JP2000086509A (ja) * 1998-09-14 2000-03-28 Taisho Yakuhin Kogyo Kk ソファルコン含有製剤の製造方法
FR2783421B1 (fr) * 1998-09-17 2000-11-24 Cll Pharma Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
US6368620B2 (en) * 1999-06-11 2002-04-09 Abbott Laboratories Formulations comprising lipid-regulating agents
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US6667064B2 (en) 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
AU6294501A (en) * 2000-09-20 2002-04-02 Rtp Pharma Inc Spray drying process and compositions of fenofibrate
US8026281B2 (en) * 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate

Also Published As

Publication number Publication date
TR200200008T2 (tr) 2002-06-21
AU782282B2 (en) 2005-07-14
ATE291912T1 (de) 2005-04-15
CN1682707A (zh) 2005-10-19
ATE399006T1 (de) 2008-07-15
KR100766644B1 (ko) 2007-10-15
DE60031184T2 (de) 2007-08-23
GEP20043287B (en) 2004-07-26
PT1194140E (pt) 2005-07-29
UA72925C2 (uk) 2005-05-16
EA200200147A1 (ru) 2002-06-27
CA2377909A1 (fr) 2001-01-18
DK1194140T3 (da) 2005-07-04
US20080248101A1 (en) 2008-10-09
HUP0202338A3 (en) 2003-03-28
MXPA02000324A (es) 2002-06-21
EP1194140A1 (fr) 2002-04-10
JP2011148813A (ja) 2011-08-04
BR0012335A (pt) 2002-03-19
ES2235919T3 (es) 2005-07-16
HRP20020111A2 (en) 2003-04-30
HUP0202338A2 (en) 2002-10-28
EP1523983B1 (fr) 2008-06-25
CN1204885C (zh) 2005-06-08
DK1523983T3 (da) 2008-10-13
DE60039313D1 (de) 2008-08-07
SK287484B6 (sk) 2010-11-08
ES2271924T3 (es) 2007-04-16
ME01361B (me) 2008-11-28
ATE341320T1 (de) 2006-10-15
CN1682707B (zh) 2010-05-05
HK1044894A1 (en) 2002-11-08
HRP20020111B1 (en) 2005-12-31
CZ20022A3 (cs) 2002-05-15
PT1523983E (pt) 2008-09-19
US7101574B1 (en) 2006-09-05
HK1080391A1 (en) 2006-04-28
YU93201A (sh) 2004-09-03
BG106280A (en) 2002-08-30
SK152002A3 (en) 2002-07-02
DE60019120D1 (de) 2005-05-04
KR20020025188A (ko) 2002-04-03
JP4841092B2 (ja) 2011-12-21
ES2309438T3 (es) 2008-12-16
BG65504B1 (bg) 2008-10-31
EE04995B1 (et) 2008-04-15
JP2003504331A (ja) 2003-02-04
DE60031184D1 (de) 2006-11-16
KR20060073549A (ko) 2006-06-28
HK1044894B (zh) 2005-06-24
SI1194140T1 (en) 2005-06-30
WO2001003693A1 (fr) 2001-01-18
NO20020014D0 (no) 2002-01-02
SI1574214T1 (sl) 2006-12-31
IS2157B (is) 2006-11-15
CN1360499A (zh) 2002-07-24
EP1194140B1 (fr) 2005-03-30
CA2377909C (fr) 2011-06-28
KR20070026716A (ko) 2007-03-08
IS6218A (is) 2002-01-03
FR2795961A1 (fr) 2001-01-12
EA004294B1 (ru) 2004-02-26
ZA200200169B (en) 2002-07-31
AU6296000A (en) 2001-01-30
EE200200011A (et) 2003-02-17
US20070071812A1 (en) 2007-03-29
US8658212B2 (en) 2014-02-25
EP1574214A1 (fr) 2005-09-14
NO333301B1 (no) 2013-04-29
DE60019120T2 (de) 2006-02-09
PL352307A1 (en) 2003-08-11
EP1523983A1 (fr) 2005-04-20
IL147499A0 (en) 2002-08-14
NZ516416A (en) 2003-10-31
US8563042B2 (en) 2013-10-22
DK1574214T3 (da) 2007-01-22
HK1074588A1 (en) 2005-11-18
FR2795961B1 (fr) 2004-05-28
CZ300094B6 (cs) 2009-01-28
CY1106206T1 (el) 2011-06-08
EP1574214B1 (fr) 2006-10-04
US20110159082A1 (en) 2011-06-30
IL147499A (en) 2007-03-08
PL212082B1 (pl) 2012-08-31
PT1574214E (pt) 2007-01-31
HU229044B1 (hu) 2013-07-29
NO20020014L (no) 2002-03-04

Similar Documents

Publication Publication Date Title
RS50035B (sr) Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje
MD1315B1 (en) Oxim esters and intermediate compositions, process for preparation thereof, compositions, process for pests control.
ATE218154T1 (de) Physikalisch modifizierte abbaubare thermoplastische zusammensetzung
DE60037726D1 (de) Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
YU149791A (sh) Mometason, furoat monohidrat i postupak za njegovo dobijanje
ES2124424T3 (es) Azadioxacicloalquenos substituidos y su empleo como fungicidas.
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
MY115339A (en) Compositions containing micronized nebivolol
RS49633B (sr) Farmaceutske formulacije koje sadrže vorikonazol
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
DE69705300T2 (de) Cyclopropylalkansäurederivate
BR9811099A (pt) Inibidores de urocinase
RS49723B (sr) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
ME00113B (me) Estri l-karnitina ili alkanoil l-karnitina korisni kao katjonski lipidi za unutarćelijsko oslobađanje farmakološki aktivnih jedinjenja
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
TR200000153T2 (tr) İl-5 inhibite eden 6-azaurasil türevleri.
RU94038042A (ru) Производные гексагидроазепинов, фармацевтическая композиция на их основе и антипсихотропный агент
BR0011174A (pt) Composições, compostos, compostos isolados e métodos para controlar pestes
GB0118300D0 (en) Formulations
TNSN03065A1 (en) BIOPESTICIDE COMPOSITIONS
YU31191A (sh) Novi derivati beta-fenilizoserina njegovo dobijanje i primena
ATE127465T1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
IT1274483B (it) Composizioni farmaceutiche contenenti gemfibrozil
RS49962B (sr) Peroralne kompozicije koje kontrolisano oslobađaju levosimendan